{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:17:13Z","timestamp":1776464233147,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004342","name":"Wyeth","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prevnar7"},{"name":"Prevnar 13","award":["0887Z1-4603"],"award-info":[{"award-number":["0887Z1-4603"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.03.031","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T16:20:42Z","timestamp":1490199642000},"page":"2449-2456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The herd effects of infant PCV7\/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel"],"prefix":"10.1016","volume":"35","author":[{"given":"Gili","family":"Regev-Yochay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Katzir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Strahilevitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talya","family":"Finn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Miron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin","family":"Maor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibiana","family":"Chazan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehudith","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2017.03.031_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/1469-0691.12461","article-title":"Pneumococcal infection in adults: burden of disease","volume":"20","author":"Drijkoningen","year":"2014","journal-title":"Clin Microbiol Infect: Off Publ Eur Soc Clin Microbiol Infect Dis"},{"issue":"46","key":"10.1016\/j.vaccine.2017.03.031_b0010","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1016\/j.vaccine.2012.08.012","article-title":"Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel","volume":"30","author":"Ben-Shimol","year":"2012","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2017.03.031_b0015","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.vaccine.2015.01.030","article-title":"Early impact of PCV7\/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: a nationwide surveillance study","volume":"33","author":"Regev-Yochay","year":"2015","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2017.03.031_b0020","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: comparison between meningitis and non-meningitis IPD","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.031_b0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/INF.0000000000000604","article-title":"Differential impact of pneumococcal conjugate vaccines on bacteremic pneumonia versus other invasive pneumococcal disease","volume":"34","author":"Ben-Shimol","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2017.03.031_b0030","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/cid\/ciw175","article-title":"Influence of childhood pneumococcal conjugate vaccines on invasive pneumococcal disease in adults with underlying comorbidities in Calgary, Alberta (2000\u20132013)","volume":"62","author":"Cabaj","year":"2016","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"5","key":"10.1016\/j.vaccine.2017.03.031_b0035","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2017.03.031_b0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/cid\/ciu524","article-title":"Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality","volume":"59","author":"Harboe","year":"2014","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.031_b0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2017.03.031_b0050","doi-asserted-by":"crossref","first-page":"D60","DOI":"10.1016\/j.vaccine.2015.05.102","article-title":"Pneumococcal disease prevention among adults: Strategies for the use of pneumococcal vaccines","volume":"33","author":"Pilishvili","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2017.03.031_b0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.031_b0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/21645515.2015.1117713","article-title":"Evaluating the impact of PCV-10 on invasive pneumococcal disease in Brazil: a time-series analysis","volume":"12","author":"Andrade","year":"2016","journal-title":"Hum Vacc Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2017.03.031_b0065","doi-asserted-by":"crossref","first-page":"e0131117","DOI":"10.1371\/journal.pone.0131117","article-title":"The Czech surveillance system for invasive pneumococcal disease, 2008\u20132013: A FOLLOW-UP ASSESSMENT AND SENSITIVITY ESTIMATION","volume":"10","author":"Stock","year":"2015","journal-title":"PLoS ONE"},{"issue":"26","key":"10.1016\/j.vaccine.2017.03.031_b0070","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1016\/j.vaccine.2012.03.060","article-title":"Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme","volume":"30","author":"Ingels","year":"2012","journal-title":"Vaccine"},{"issue":"27","key":"10.1016\/j.vaccine.2017.03.031_b0075","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1016\/j.vaccine.2014.03.065","article-title":"Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance","volume":"32","author":"Ben-Shimol","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.031_b0080","doi-asserted-by":"crossref","first-page":"e0149540","DOI":"10.1371\/journal.pone.0149540","article-title":"Cost-effectiveness of vaccinating immunocompetent \u226565 year olds with the 13-valent pneumococcal conjugate vaccine in England","volume":"11","author":"van Hoek","year":"2016","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2017.03.031_b0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1185\/03007995.2015.1131150","article-title":"Pneumococcal pneumonia prevention among adults: is the herd effect of pneumococcal conjugate vaccination in children as good a way as the active immunization of the elderly?","volume":"32","author":"Prato","year":"2016","journal-title":"Curr Med Res Opin"},{"issue":"6 Suppl 4","key":"10.1016\/j.vaccine.2017.03.031_b0090","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.amepre.2015.09.008","article-title":"Pneumococcal disease prevention among adults: strategies for the use of pneumococcal vaccines","volume":"49","author":"Pilishvili","year":"2015","journal-title":"Am J Prev Med"},{"issue":"4","key":"10.1016\/j.vaccine.2017.03.031_b0095","first-page":"93","article-title":"Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years\u2013United States, 2015","volume":"64","author":"Strikas","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2017.03.031_b0100","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/21645515.2015.1098794","article-title":"Why the recent ACIP recommendations regarding conjugate pneumococcal vaccine in adults may be irrelevant","volume":"12","author":"Musher","year":"2016","journal-title":"Hum Vacc Immunother"},{"issue":"8862","key":"10.1016\/j.vaccine.2017.03.031_b0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/0140-6736(93)91887-R","article-title":"Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia","volume":"342","author":"Brancati","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2017.03.031_b0110","unstructured":"http:\/\/www.health.gov.il\/English\/MinsistryUnits\/ICDC\/Infectious_diseases\/Flu\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17303377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T09:00:45Z","timestamp":1535965245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17303377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":22,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17303377"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The herd effects of infant PCV7\/PCV13 sequential implementation on adult invasive pneumococcal disease, six years post implementation; a nationwide study in Israel","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}